|
1
|
Al Mazrouei SK, Moore J, Ahmed F, Mikula
EB and Martin GR: Regional implementation of newborn screening for
critical congenital heart disease screening in Abu Dhabi. Pediatr
Cardiol. 34:1299–1306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dale MT, Solberg O, Holmstrøm H, Landolt
MA, Eskedal LT and Vollrath ME: Mothers of infants with congenital
heart defects: Well-being from pregnancy through the child's first
six months. Qual Life Res. 21:115–122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ratanachu-Ek S and Pongdara A: Nutritional
status of pediatric patients with congenital heart disease: Pre-
and post cardiac surgery. J Med Assoc Thai. 94:(Suppl 3).
S133–S137. 2011.PubMed/NCBI
|
|
4
|
Moons P, Bovijn L, Budts W and Gewillig M:
Abstract 1866: Actual prospects to survive into adulthood in
patients with congenital heart disease. Circulation. 120:(Suppl).
S5612009.
|
|
5
|
Song R: Expression and function of small
non-coding RNAs in the mouse testis. PhD dissertation. University
of Nevada. ProQuest/UMI, Publication no. AAT 3472784. Reno, NV:
2011
|
|
6
|
Moll R, Sievers E, Hämmerling B, Schmidt
A, Barth M, Kuhn C, Grund C, Hofmann I and Franke WW: Endothelial
and virgultar cell formations in the mammalian lymph node sinus:
Endothelial differentiation morphotypes characterized by a special
kind of junction (complexus adhaerens). Cell Tissue Res.
335:109–141. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawashima K and Koshimizu U: Method for
proliferation cardiomyocytes using micro-rna. US Patent 20140213634
A1. Filed April 4, 2014; issued July 31. 2014.
|
|
8
|
L'Honore A, Rana V, Arsic N, Franckhauser
C, Lamb NJ and Fernandez A: Identification of a new hybrid serum
response factor and myocyte enhancer factor 2-binding element in
MyoD enhancer required for MyoD expression during myogenesis. Mol
Biol Cell. 18:1992–2001. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H,
Xiao J, Shan H, Wang Z and Yang B: The muscle-specific microRNAs
miR-1 and miR-133 produce opposing effects on apoptosis by
targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci.
120:3045–3052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grobe JL, Mecca AP, Lingis M, Shenoy V,
Bolton TA, Machado JM, Speth RC, Raizada MK and Katovich MJ:
Prevention of angiotensin II-induced cardiac remodeling by
angiotensin-(1–7). Am J Physiol Heart Circ Physiol. 292:H736–H742.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McBurney MW, Jones-Villeneuve EM, Edwards
MK and Anderson PJ: Control of muscle and neuronal differentiation
in a cultured embryonal carcinoma cell line. Nature. 299:165–167.
1982. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi SC, Choi JH, Shim WJ and Lim DS: P19
Embryonal carcinoma cells: A new model for the study of endothelial
cell differentiation. Biotechnol Lett. 30:1169–1175. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paquin J, Danalache BA, Jankowski M,
McCann SM and Gutkowska J: Oxytocin induces differentiation of P19
embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA.
99:9550–9555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arseculeratne SN, Atapattu DN, Kumarasiri
R, Perera D, Ekanayake D and Rajapakse J: The use of MTT [3-(4,
5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide]-
reduction as an indicator of the effects of strain-specific,
polyclonal rabbit antisera on Candida albicans and C. Indian J Med
Microbiol. 25:267–271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Methods. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Izarra A, Moscoso I, Cañón S, Carreiro C,
Fondevila D, Martín-Caballero J, Blanca V, Valiente I, Díez-Juan A
and Bernad A: miRNA-1 and miRNA-133a are involved in early
commitment of pluripotent stem cells and demonstrate antagonistic
roles in the regulation of cardiac differentiation. J Tissue Eng
Regen Med. Dec 10–2014.(Epub ahead of print). PubMed/NCBI
|
|
17
|
Brown CO III, Chi X, Garcia-Gras E, Shirai
M, Feng XH and Schwartz RJ: The cardiac determination factor,
Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a
novel upstream enhancer. J Biol Chem. 279:10659–10669. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haveri H, Ashorn M, Iltanen S, Wilson DB,
Andersson LC and Heikinheimo M: Enhanced expression of
transcription factor GATA4 in inflammatory bowel disease and its
possible regulation by TGF-beta1. J Clin Immunol. 29:444–453. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y and Xiao-Yu HE: Expression of the
transcription factor GATA-4 in human heart development. J Med
Postg. 2008.
|
|
20
|
Zaglia T, Dedja A, Candiotto C, Cozzi E,
Schiaffino S and Ausoni S: Cardiac interstitial cells express GATA4
and control dedifferentiation and cell cycle re-entry of adult
cardiomyocytes. J Mol Cell Cardiol. 46:653–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thomson JM, Newman M, Parker JS,
Morin-Kensicki EM, Wright T and Hammond SM: Extensive
post-transcriptional regulation of microRNAs and its implications
for cancer. Gene Dev. 20:2202–2207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JF, Mandel EM, Thomson JM, Wu Q,
Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nasser MW, Datta J, Nuovo G, Kutay H,
Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
VanDusen NJ, Casanovas J, Vincentz JW,
Firulli BA, Osterwalder M, Lopez-Rios J, Zeller R, Zhou B,
Grego-Bessa J, De La Pompa JL, et al: Hand2 is an essential
regulator for two Notch-dependent functions within the embryonic
endocardium. Cell Rep. 9:2071–2083. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yelon D, Ticho B, Halpern ME, Ruvinsky I,
Ho RK, Silver LM and Stainier DY: The bHLH transcription factor
hand2 plays parallel roles in zebrafish heart and pectoral fin
development. Development. 127:2573–2582. 2000.PubMed/NCBI
|
|
26
|
Olson EN: Gene regulatory networks in the
evolution and development of the heart. Science. 313:1922–1927.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun J, Shen X, Xie B, Zhong YS, Lu Q and
Sun Y: Effects of high glucose on apoptosis of human umbilical vein
endothelial cells and expression of Caspase-3. J Shang Jiaotong
Univ. 34:1709–1713. 2014.
|
|
28
|
Isa SA, Mainwaring LS, Webb R and Thomas
AW: The non-genomic effects of high doses of Rosiglitazone on cell
growth and apoptosis in cultured monocytic cells. Bayero J Pure
Appl Sci. 2:1–8. 2009.
|
|
29
|
Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL,
Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG and Yu XY: Upregulated
expression of miR-1/miR-206 in a rat model of myocardial
infarction. Biochem Biophys Res Commun. 381:597–601. 2009.
View Article : Google Scholar : PubMed/NCBI
|
